Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repare Therapeutics Inc. - Common Shares (NQ:RPTX)

1.720 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.720
Bid (Size) 1.690 (300)
Ask (Size) 1.860 (700)
Prev. Close 1.720
Today's Range 1.720 - 1.720
52wk Range 0.8900 - 4.069
Shares Outstanding 42,088,446
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
From Repare Therapeutics Inc.
Via Business Wire
News headline image
Repare (RPTX) Q2 Loss Narrows 52% ↗
Via The Motley Fool

Performance

YTD
+30.3%
+30.3%
1 Month
-5.5%
-5.5%
3 Month
+8.2%
+8.2%
6 Month
+31.8%
+31.8%
1 Year
-50.8%
-50.8%

More News

Read More
News headline image
Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
From Repare Therapeutics Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
Repare Therapeutics Jumps After Hours On $267M Global Licensing Deal With Debiopharm; Retail Traders Rush In ↗
Via Stocktwits
News headline image
Why Data Storage Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
Tuesday's after hours session: top gainers and losers ↗
Via Chartmill
News headline image
Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib
From Repare Therapeutics Inc.
Via Business Wire
News headline image
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results
From Repare Therapeutics Inc.
Via Business Wire
News headline image
Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics
From Repare Therapeutics Inc.
Via Business Wire
News headline image
Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
From Repare Therapeutics Inc.
Via Business Wire
News headline image
Cathie Wood's Ark Invest Offloads Uipath, Prime Medicine, And Repare Therapeutics ↗
Via Benzinga
News headline image
Cathie Wood's Ark Invest Loads Up On Amazon, Coinbase: Offloads UiPath, Roblox ↗
Via Benzinga
News headline image
Cathie Wood Doubles Down: Mops Up Another $1.39 Million Worth Of Robinhood Stock Amid Trump Tariff Dip ↗
Via Benzinga
Topics Government
News headline image
Repare Therapeutics Announces Leadership Transitions
From Repare Therapeutics Inc.
Via Business Wire
News headline image
Cathie Wood's Ark Invest Loads Up On Robinhood, Nvidia-Backed CoreWeave: Offloads Spotify, Roku ↗
Via Benzinga
News headline image
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen ↗
Via Benzinga
News headline image
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta ↗
Via Benzinga
News headline image
Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Repare Therapeutics Inc.
Via Business Wire
News headline image
Gap To Rally Over 69%? Here Are 10 Top Analyst Forecasts For Friday ↗
Via Benzinga
News headline image
Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results
From Repare Therapeutics Inc.
Via Business Wire
News headline image
Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions
From Repare Therapeutics Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet ↗
Via Benzinga

Frequently Asked Questions

Is Repare Therapeutics Inc. - Common Shares publicly traded?
Yes, Repare Therapeutics Inc. - Common Shares is publicly traded.
What exchange does Repare Therapeutics Inc. - Common Shares trade on?
Repare Therapeutics Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Repare Therapeutics Inc. - Common Shares?
The ticker symbol for Repare Therapeutics Inc. - Common Shares is RPTX on the Nasdaq Stock Market
What is the current price of Repare Therapeutics Inc. - Common Shares?
The current price of Repare Therapeutics Inc. - Common Shares is 1.720
When was Repare Therapeutics Inc. - Common Shares last traded?
The last trade of Repare Therapeutics Inc. - Common Shares was at 11/12/25 04:00 PM ET
What is the market capitalization of Repare Therapeutics Inc. - Common Shares?
The market capitalization of Repare Therapeutics Inc. - Common Shares is 72.39M
How many shares of Repare Therapeutics Inc. - Common Shares are outstanding?
Repare Therapeutics Inc. - Common Shares has 72M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.